1 Market Overview

1.1 Product Overview and Scope of Oligonucleotide Synthesis Services

1.2 Classification of Oligonucleotide Synthesis Services by Type

1.2.1 Overview: Global Oligonucleotide Synthesis Services Market Size by Type: 2017 Versus 2021 Versus 2028

1.2.2 Global Oligonucleotide Synthesis Services Revenue Market Share by Type in 2021

1.2.3 Primers

1.2.4 Probes

1.2.5 Intermediate-scale Synthesis Oligos

1.2.6 Large-scale Synthesis Oligos

1.2.7 Linkers and Adaptors

1.3 Global Oligonucleotide Synthesis Services Market by Application

1.3.1 Overview: Global Oligonucleotide Synthesis Services Market Size by Application: 2017 Versus 2021 Versus 2028

1.3.2 Commercial

1.3.3 Academic Research

1.4 Global Oligonucleotide Synthesis Services Market Size & Forecast

1.5 Global Oligonucleotide Synthesis Services Market Size and Forecast by Region

1.5.1 Global Oligonucleotide Synthesis Services Market Size by Region: 2017 VS 2021 VS 2028

1.5.2 Global Oligonucleotide Synthesis Services Market Size by Region, (2017-2022)

1.5.3 North America Oligonucleotide Synthesis Services Market Size and Prospect (2017-2028)

1.5.4 Europe Oligonucleotide Synthesis Services Market Size and Prospect (2017-2028)

1.5.5 Asia-Pacific Oligonucleotide Synthesis Services Market Size and Prospect (2017-2028)

1.5.6 South America Oligonucleotide Synthesis Services Market Size and Prospect (2017-2028)

1.5.7 Middle East and Africa Oligonucleotide Synthesis Services Market Size and Prospect (2017-2028)

1.6 Market Drivers, Restraints and Trends

1.6.1 Oligonucleotide Synthesis Services Market Drivers

1.6.2 Oligonucleotide Synthesis Services Market Restraints

1.6.3 Oligonucleotide Synthesis Services Trends Analysis

2 Company Profiles

2.1 Genescript

2.1.1 Genescript Details

2.1.2 Genescript Major Business

2.1.3 Genescript Oligonucleotide Synthesis Services Product and Solutions

2.1.4 Genescript Oligonucleotide Synthesis Services Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.1.5 Genescript Recent Developments and Future Plans

2.2 GeneArt (Thermofischer)

2.2.1 GeneArt (Thermofischer) Details

2.2.2 GeneArt (Thermofischer) Major Business

2.2.3 GeneArt (Thermofischer) Oligonucleotide Synthesis Services Product and Solutions

2.2.4 GeneArt (Thermofischer) Oligonucleotide Synthesis Services Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.2.5 GeneArt (Thermofischer) Recent Developments and Future Plans

2.3 Renesas Electronics Corporation

2.3.1 Renesas Electronics Corporation Details

2.3.2 Renesas Electronics Corporation Major Business

2.3.3 Renesas Electronics Corporation Oligonucleotide Synthesis Services Product and Solutions

2.3.4 Renesas Electronics Corporation Oligonucleotide Synthesis Services Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.3.5 Renesas Electronics Corporation Recent Developments and Future Plans

2.4 DNA 2.0 (ATUM)

2.4.1 DNA 2.0 (ATUM) Details

2.4.2 DNA 2.0 (ATUM) Major Business

2.4.3 DNA 2.0 (ATUM) Oligonucleotide Synthesis Services Product and Solutions

2.4.4 DNA 2.0 (ATUM) Oligonucleotide Synthesis Services Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.4.5 DNA 2.0 (ATUM) Recent Developments and Future Plans

2.5 OriGene

2.5.1 OriGene Details

2.5.2 OriGene Major Business

2.5.3 OriGene Oligonucleotide Synthesis Services Product and Solutions

2.5.4 OriGene Oligonucleotide Synthesis Services Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.5.5 OriGene Recent Developments and Future Plans

2.6 BBI

2.6.1 BBI Details

2.6.2 BBI Major Business

2.6.3 BBI Oligonucleotide Synthesis Services Product and Solutions

2.6.4 BBI Oligonucleotide Synthesis Services Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.6.5 BBI Recent Developments and Future Plans

2.7 Genewiz

2.7.1 Genewiz Details

2.7.2 Genewiz Major Business

2.7.3 Genewiz Oligonucleotide Synthesis Services Product and Solutions

2.7.4 Genewiz Oligonucleotide Synthesis Services Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.7.5 Genewiz Recent Developments and Future Plans

2.8 Eurofins Genomics

2.8.1 Eurofins Genomics Details

2.8.2 Eurofins Genomics Major Business

2.8.3 Eurofins Genomics Oligonucleotide Synthesis Services Product and Solutions

2.8.4 Eurofins Genomics Oligonucleotide Synthesis Services Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.8.5 Eurofins Genomics Recent Developments and Future Plans

2.9 Gene Oracle

2.9.1 Gene Oracle Details

2.9.2 Gene Oracle Major Business

2.9.3 Gene Oracle Oligonucleotide Synthesis Services Product and Solutions

2.9.4 Gene Oracle Oligonucleotide Synthesis Services Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.9.5 Gene Oracle Recent Developments and Future Plans

2.10 SBS Genetech

2.10.1 SBS Genetech Details

2.10.2 SBS Genetech Major Business

2.10.3 SBS Genetech Oligonucleotide Synthesis Services Product and Solutions

2.10.4 SBS Genetech Oligonucleotide Synthesis Services Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.10.5 SBS Genetech Recent Developments and Future Plans

2.11 Bio Basic

2.11.1 Bio Basic Details

2.11.2 Bio Basic Major Business

2.11.3 Bio Basic Oligonucleotide Synthesis Services Product and Solutions

2.11.4 Bio Basic Oligonucleotide Synthesis Services Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.11.5 Bio Basic Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global Oligonucleotide Synthesis Services Revenue and Share by Players (2019, 2020, 2021, and 2022)

3.2 Market Concentration Rate

3.2.1 Top 3 Oligonucleotide Synthesis Services Players Market Share in 2021

3.2.2 Top 10 Oligonucleotide Synthesis Services Players Market Share in 2021

3.2.3 Market Competition Trend

3.3 Oligonucleotide Synthesis Services Players Head Office, Products and Services Provided

3.4 Oligonucleotide Synthesis Services Mergers & Acquisitions

3.5 Oligonucleotide Synthesis Services New Entrants and Expansion Plans

4 Market Size Segment by Type

4.1 Global Oligonucleotide Synthesis Services Revenue and Market Share by Type (2017-2022)

4.2 Global Oligonucleotide Synthesis Services Market Forecast by Type (2023-2028)

5 Market Size Segment by Application

5.1 Global Oligonucleotide Synthesis Services Revenue Market Share by Application (2017-2022)

5.2 Global Oligonucleotide Synthesis Services Market Forecast by Application (2023-2028)

6 North America by Country, by Type, and by Application

6.1 North America Oligonucleotide Synthesis Services Revenue by Type (2017-2028)

6.2 North America Oligonucleotide Synthesis Services Revenue by Application (2017-2028)

6.3 North America Oligonucleotide Synthesis Services Market Size by Country

6.3.1 North America Oligonucleotide Synthesis Services Revenue by Country (2017-2028)

6.3.2 United States Oligonucleotide Synthesis Services Market Size and Forecast (2017-2028)

6.3.3 Canada Oligonucleotide Synthesis Services Market Size and Forecast (2017-2028)

6.3.4 Mexico Oligonucleotide Synthesis Services Market Size and Forecast (2017-2028)

7 Europe by Country, by Type, and by Application

7.1 Europe Oligonucleotide Synthesis Services Revenue by Type (2017-2028)

7.2 Europe Oligonucleotide Synthesis Services Revenue by Application (2017-2028)

7.3 Europe Oligonucleotide Synthesis Services Market Size by Country

7.3.1 Europe Oligonucleotide Synthesis Services Revenue by Country (2017-2028)

7.3.2 Germany Oligonucleotide Synthesis Services Market Size and Forecast (2017-2028)

7.3.3 France Oligonucleotide Synthesis Services Market Size and Forecast (2017-2028)

7.3.4 United Kingdom Oligonucleotide Synthesis Services Market Size and Forecast (2017-2028)

7.3.5 Russia Oligonucleotide Synthesis Services Market Size and Forecast (2017-2028)

7.3.6 Italy Oligonucleotide Synthesis Services Market Size and Forecast (2017-2028)

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific Oligonucleotide Synthesis Services Revenue by Type (2017-2028)

8.2 Asia-Pacific Oligonucleotide Synthesis Services Revenue by Application (2017-2028)

8.3 Asia-Pacific Oligonucleotide Synthesis Services Market Size by Region

8.3.1 Asia-Pacific Oligonucleotide Synthesis Services Revenue by Region (2017-2028)

8.3.2 China Oligonucleotide Synthesis Services Market Size and Forecast (2017-2028)

8.3.3 Japan Oligonucleotide Synthesis Services Market Size and Forecast (2017-2028)

8.3.4 South Korea Oligonucleotide Synthesis Services Market Size and Forecast (2017-2028)

8.3.5 India Oligonucleotide Synthesis Services Market Size and Forecast (2017-2028)

8.3.6 Southeast Asia Oligonucleotide Synthesis Services Market Size and Forecast (2017-2028)

8.3.7 Australia Oligonucleotide Synthesis Services Market Size and Forecast (2017-2028)

9 South America by Country, by Type, and by Application

9.1 South America Oligonucleotide Synthesis Services Revenue by Type (2017-2028)

9.2 South America Oligonucleotide Synthesis Services Revenue by Application (2017-2028)

9.3 South America Oligonucleotide Synthesis Services Market Size by Country

9.3.1 South America Oligonucleotide Synthesis Services Revenue by Country (2017-2028)

9.3.2 Brazil Oligonucleotide Synthesis Services Market Size and Forecast (2017-2028)

9.3.3 Argentina Oligonucleotide Synthesis Services Market Size and Forecast (2017-2028)

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa Oligonucleotide Synthesis Services Revenue by Type (2017-2028)

10.2 Middle East & Africa Oligonucleotide Synthesis Services Revenue by Application (2017-2028)

10.3 Middle East & Africa Oligonucleotide Synthesis Services Market Size by Country

10.3.1 Middle East & Africa Oligonucleotide Synthesis Services Revenue by Country (2017-2028)

10.3.2 Turkey Oligonucleotide Synthesis Services Market Size and Forecast (2017-2028)

10.3.3 Saudi Arabia Oligonucleotide Synthesis Services Market Size and Forecast (2017-2028)

10.3.4 UAE Oligonucleotide Synthesis Services Market Size and Forecast (2017-2028)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global Oligonucleotide Synthesis Services Revenue by Type, (USD Million), 2017 VS 2021 VS 2028

Table 2. Global Oligonucleotide Synthesis Services Revenue by Application, (USD Million), 2017 VS 2021 VS 2028

Table 3. Global Market Oligonucleotide Synthesis Services Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)

Table 4. Global Oligonucleotide Synthesis Services Revenue (USD Million) by Region (2017-2022)

Table 5. Global Oligonucleotide Synthesis Services Revenue Market Share by Region (2023-2028)

Table 6. Genescript Corporate Information, Head Office, and Major Competitors

Table 7. Genescript Major Business

Table 8. Genescript Oligonucleotide Synthesis Services Product and Solutions

Table 9. Genescript Oligonucleotide Synthesis Services Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 10. GeneArt (Thermofischer) Corporate Information, Head Office, and Major Competitors

Table 11. GeneArt (Thermofischer) Major Business

Table 12. GeneArt (Thermofischer) Oligonucleotide Synthesis Services Product and Solutions

Table 13. GeneArt (Thermofischer) Oligonucleotide Synthesis Services Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 14. Renesas Electronics Corporation Corporate Information, Head Office, and Major Competitors

Table 15. Renesas Electronics Corporation Major Business

Table 16. Renesas Electronics Corporation Oligonucleotide Synthesis Services Product and Solutions

Table 17. Renesas Electronics Corporation Oligonucleotide Synthesis Services Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 18. DNA 2.0 (ATUM) Corporate Information, Head Office, and Major Competitors

Table 19. DNA 2.0 (ATUM) Major Business

Table 20. DNA 2.0 (ATUM) Oligonucleotide Synthesis Services Product and Solutions

Table 21. DNA 2.0 (ATUM) Oligonucleotide Synthesis Services Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 22. OriGene Corporate Information, Head Office, and Major Competitors

Table 23. OriGene Major Business

Table 24. OriGene Oligonucleotide Synthesis Services Product and Solutions

Table 25. OriGene Oligonucleotide Synthesis Services Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 26. BBI Corporate Information, Head Office, and Major Competitors

Table 27. BBI Major Business

Table 28. BBI Oligonucleotide Synthesis Services Product and Solutions

Table 29. BBI Oligonucleotide Synthesis Services Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 30. Genewiz Corporate Information, Head Office, and Major Competitors

Table 31. Genewiz Major Business

Table 32. Genewiz Oligonucleotide Synthesis Services Product and Solutions

Table 33. Genewiz Oligonucleotide Synthesis Services Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 34. Eurofins Genomics Corporate Information, Head Office, and Major Competitors

Table 35. Eurofins Genomics Major Business

Table 36. Eurofins Genomics Oligonucleotide Synthesis Services Product and Solutions

Table 37. Eurofins Genomics Oligonucleotide Synthesis Services Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 38. Gene Oracle Corporate Information, Head Office, and Major Competitors

Table 39. Gene Oracle Major Business

Table 40. Gene Oracle Oligonucleotide Synthesis Services Product and Solutions

Table 41. Gene Oracle Oligonucleotide Synthesis Services Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 42. SBS Genetech Corporate Information, Head Office, and Major Competitors

Table 43. SBS Genetech Major Business

Table 44. SBS Genetech Oligonucleotide Synthesis Services Product and Solutions

Table 45. SBS Genetech Oligonucleotide Synthesis Services Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 46. Bio Basic Corporate Information, Head Office, and Major Competitors

Table 47. Bio Basic Major Business

Table 48. Bio Basic Oligonucleotide Synthesis Services Product and Solutions

Table 49. Bio Basic Oligonucleotide Synthesis Services Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 50. Global Oligonucleotide Synthesis Services Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)

Table 51. Global Oligonucleotide Synthesis Services Revenue Share by Players (2019, 2020, 2021, and 2022)

Table 52. Breakdown of Oligonucleotide Synthesis Services by Company Type (Tier 1, Tier 2 and Tier 3)

Table 53. Oligonucleotide Synthesis Services Players Head Office, Products and Services Provided

Table 54. Oligonucleotide Synthesis Services Mergers & Acquisitions in the Past Five Years

Table 55. Oligonucleotide Synthesis Services New Entrants and Expansion Plans

Table 56. Global Oligonucleotide Synthesis Services Revenue (USD Million) by Type (2017-2022)

Table 57. Global Oligonucleotide Synthesis Services Revenue Share by Type (2017-2022)

Table 58. Global Oligonucleotide Synthesis Services Revenue Forecast by Type (2023-2028)

Table 59. Global Oligonucleotide Synthesis Services Revenue by Application (2017-2022)

Table 60. Global Oligonucleotide Synthesis Services Revenue Forecast by Application (2023-2028)

Table 61. North America Oligonucleotide Synthesis Services Revenue by Type (2017-2022) & (USD Million)

Table 62. North America Oligonucleotide Synthesis Services Revenue by Type (2023-2028) & (USD Million)

Table 63. North America Oligonucleotide Synthesis Services Revenue by Application (2017-2022) & (USD Million)

Table 64. North America Oligonucleotide Synthesis Services Revenue by Application (2023-2028) & (USD Million)

Table 65. North America Oligonucleotide Synthesis Services Revenue by Country (2017-2022) & (USD Million)

Table 66. North America Oligonucleotide Synthesis Services Revenue by Country (2023-2028) & (USD Million)

Table 67. Europe Oligonucleotide Synthesis Services Revenue by Type (2017-2022) & (USD Million)

Table 68. Europe Oligonucleotide Synthesis Services Revenue by Type (2023-2028) & (USD Million)

Table 69. Europe Oligonucleotide Synthesis Services Revenue by Application (2017-2022) & (USD Million)

Table 70. Europe Oligonucleotide Synthesis Services Revenue by Application (2023-2028) & (USD Million)

Table 71. Europe Oligonucleotide Synthesis Services Revenue by Country (2017-2022) & (USD Million)

Table 72. Europe Oligonucleotide Synthesis Services Revenue by Country (2023-2028) & (USD Million)

Table 73. Asia-Pacific Oligonucleotide Synthesis Services Revenue by Type (2017-2022) & (USD Million)

Table 74. Asia-Pacific Oligonucleotide Synthesis Services Revenue by Type (2023-2028) & (USD Million)

Table 75. Asia-Pacific Oligonucleotide Synthesis Services Revenue by Application (2017-2022) & (USD Million)

Table 76. Asia-Pacific Oligonucleotide Synthesis Services Revenue by Application (2023-2028) & (USD Million)

Table 77. Asia-Pacific Oligonucleotide Synthesis Services Revenue by Region (2017-2022) & (USD Million)

Table 78. Asia-Pacific Oligonucleotide Synthesis Services Revenue by Region (2023-2028) & (USD Million)

Table 79. South America Oligonucleotide Synthesis Services Revenue by Type (2017-2022) & (USD Million)

Table 80. South America Oligonucleotide Synthesis Services Revenue by Type (2023-2028) & (USD Million)

Table 81. South America Oligonucleotide Synthesis Services Revenue by Application (2017-2022) & (USD Million)

Table 82. South America Oligonucleotide Synthesis Services Revenue by Application (2023-2028) & (USD Million)

Table 83. South America Oligonucleotide Synthesis Services Revenue by Country (2017-2022) & (USD Million)

Table 84. South America Oligonucleotide Synthesis Services Revenue by Country (2023-2028) & (USD Million)

Table 85. Middle East & Africa Oligonucleotide Synthesis Services Revenue by Type (2017-2022) & (USD Million)

Table 86. Middle East & Africa Oligonucleotide Synthesis Services Revenue by Type (2023-2028) & (USD Million)

Table 87. Middle East & Africa Oligonucleotide Synthesis Services Revenue by Application (2017-2022) & (USD Million)

Table 88. Middle East & Africa Oligonucleotide Synthesis Services Revenue by Application (2023-2028) & (USD Million)

Table 89. Middle East & Africa Oligonucleotide Synthesis Services Revenue by Country (2017-2022) & (USD Million)

Table 90. Middle East & Africa Oligonucleotide Synthesis Services Revenue by Country (2023-2028) & (USD Million)

List of Figures

Figure 1. Oligonucleotide Synthesis Services Picture

Figure 2. Global Oligonucleotide Synthesis Services Revenue Market Share by Type in 2021

Figure 3. Primers

Figure 4. Probes

Figure 5. Intermediate-scale Synthesis Oligos

Figure 6. Large-scale Synthesis Oligos

Figure 7. Linkers and Adaptors

Figure 8. Oligonucleotide Synthesis Services Revenue Market Share by Application in 2021

Figure 9. Commercial Picture

Figure 10. Academic Research Picture

Figure 11. Global Oligonucleotide Synthesis Services Market Size, (USD Million): 2017 VS 2021 VS 2028

Figure 12. Global Oligonucleotide Synthesis Services Revenue and Forecast (2017-2028) & (USD Million)

Figure 13. Global Oligonucleotide Synthesis Services Revenue Market Share by Region (2017-2028)

Figure 14. Global Oligonucleotide Synthesis Services Revenue Market Share by Region in 2021

Figure 15. North America Oligonucleotide Synthesis Services Revenue (USD Million) and Growth Rate (2017-2028)

Figure 16. Europe Oligonucleotide Synthesis Services Revenue (USD Million) and Growth Rate (2017-2028)

Figure 17. Asia-Pacific Oligonucleotide Synthesis Services Revenue (USD Million) and Growth Rate (2017-2028)

Figure 18. South America Oligonucleotide Synthesis Services Revenue (USD Million) and Growth Rate (2017-2028)

Figure 19. Middle East and Africa Oligonucleotide Synthesis Services Revenue (USD Million) and Growth Rate (2017-2028)

Figure 20. Oligonucleotide Synthesis Services Market Drivers

Figure 21. Oligonucleotide Synthesis Services Market Restraints

Figure 22. Oligonucleotide Synthesis Services Market Trends

Figure 23. Genescript Recent Developments and Future Plans

Figure 24. GeneArt (Thermofischer) Recent Developments and Future Plans

Figure 25. Renesas Electronics Corporation Recent Developments and Future Plans

Figure 26. DNA 2.0 (ATUM) Recent Developments and Future Plans

Figure 27. OriGene Recent Developments and Future Plans

Figure 28. BBI Recent Developments and Future Plans

Figure 29. Genewiz Recent Developments and Future Plans

Figure 30. Eurofins Genomics Recent Developments and Future Plans

Figure 31. Gene Oracle Recent Developments and Future Plans

Figure 32. SBS Genetech Recent Developments and Future Plans

Figure 33. Bio Basic Recent Developments and Future Plans

Figure 34. Global Oligonucleotide Synthesis Services Revenue Share by Players in 2021

Figure 35. Oligonucleotide Synthesis Services Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021

Figure 36. Global Top 3 Players Oligonucleotide Synthesis Services Revenue Market Share in 2021

Figure 37. Global Top 10 Players Oligonucleotide Synthesis Services Revenue Market Share in 2021

Figure 38. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)

Figure 39. Global Oligonucleotide Synthesis Services Revenue Share by Type in 2021

Figure 40. Global Oligonucleotide Synthesis Services Market Share Forecast by Type (2023-2028)

Figure 41. Global Oligonucleotide Synthesis Services Revenue Share by Application in 2021

Figure 42. Global Oligonucleotide Synthesis Services Market Share Forecast by Application (2023-2028)

Figure 43. North America Oligonucleotide Synthesis Services Sales Market Share by Type (2017-2028)

Figure 44. North America Oligonucleotide Synthesis Services Sales Market Share by Application (2017-2028)

Figure 45. North America Oligonucleotide Synthesis Services Revenue Market Share by Country (2017-2028)

Figure 46. United States Oligonucleotide Synthesis Services Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 47. Canada Oligonucleotide Synthesis Services Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 48. Mexico Oligonucleotide Synthesis Services Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 49. Europe Oligonucleotide Synthesis Services Sales Market Share by Type (2017-2028)

Figure 50. Europe Oligonucleotide Synthesis Services Sales Market Share by Application (2017-2028)

Figure 51. Europe Oligonucleotide Synthesis Services Revenue Market Share by Country (2017-2028)

Figure 52. Germany Oligonucleotide Synthesis Services Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 53. France Oligonucleotide Synthesis Services Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 54. United Kingdom Oligonucleotide Synthesis Services Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 55. Russia Oligonucleotide Synthesis Services Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 56. Italy Oligonucleotide Synthesis Services Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 57. Asia-Pacific Oligonucleotide Synthesis Services Sales Market Share by Type (2017-2028)

Figure 58. Asia-Pacific Oligonucleotide Synthesis Services Sales Market Share by Application (2017-2028)

Figure 59. Asia-Pacific Oligonucleotide Synthesis Services Revenue Market Share by Region (2017-2028)

Figure 60. China Oligonucleotide Synthesis Services Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 61. Japan Oligonucleotide Synthesis Services Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 62. South Korea Oligonucleotide Synthesis Services Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 63. India Oligonucleotide Synthesis Services Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 64. Southeast Asia Oligonucleotide Synthesis Services Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 65. Australia Oligonucleotide Synthesis Services Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 66. South America Oligonucleotide Synthesis Services Sales Market Share by Type (2017-2028)

Figure 67. South America Oligonucleotide Synthesis Services Sales Market Share by Application (2017-2028)

Figure 68. South America Oligonucleotide Synthesis Services Revenue Market Share by Country (2017-2028)

Figure 69. Brazil Oligonucleotide Synthesis Services Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 70. Argentina Oligonucleotide Synthesis Services Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 71. Middle East and Africa Oligonucleotide Synthesis Services Sales Market Share by Type (2017-2028)

Figure 72. Middle East and Africa Oligonucleotide Synthesis Services Sales Market Share by Application (2017-2028)

Figure 73. Middle East and Africa Oligonucleotide Synthesis Services Revenue Market Share by Country (2017-2028)

Figure 74. Turkey Oligonucleotide Synthesis Services Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 75. Saudi Arabia Oligonucleotide Synthesis Services Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 76. UAE Oligonucleotide Synthesis Services Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 77. Methodology

Figure 78. Research Process and Data Source